Category: Approval/Launch Region: Europe · Switzerland Company: Sandoz Pharmaceuticals Ag

Sandoz launches new global Act4Biosimilars initiative to improve patient access and increase adoption by at least 30% in 30+ countries by 2030

By, Admin 1 min read
Share
Sandoz launches new global Act4Biosimilars initiative to improve patient access and increase adoption by at least 30% in 30+ countries by 2030
Sandoz, a global leader in generic and biosimilar medicines, announced the launch of a new global initiative called

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!